Actos Litigation Update
On April 16, 2013, Los Angeles jurors heard closing arguments in the first trial alleging Actos causes bladder cancer. Accordingly, in a Bloomberg article Plaintiff Jack Cooper alleged that Actos, prescribed to treat his diabetes caused bladder cancer. Further, the lawsuit alleged that Takeda Pharmaceuticals, the manufacturer of Actos knew of the link to bladder cancer as early as 2004, but did not alert the FDA. Actos has been under strict scrutiny since 2011, and in 2012, the drug was criticized by both the British Medical Journal and the Canadian Medical Association Journal which linked Actos to nearly a 25% increase of risk in developing bladder cancer. At this time, 1200 Actos lawsuits are pending in the Multi District litigation located in Louisiana.
As recent as February 5, 1013, lawsuits were being filed in Cook County where nearly 1000 other claims have been presented before Judge Dooling. Similar state case consolidations are present in Pennsylvania as well. Thus, increasing the pressure on the manufacturer of the anti-diabetic drug to settle potential claims.
Takeda Pharmaceutical Co. convinced a judge to throw out a just verdict as mentioned above. The risks caused by the blockbuster diabetes drug are still present however and consumer protection attorneys across the country and in Central Illinois such as Phebus & Koester, LLP are still actively pursuing the cases. The case is far from over as the attorneys for the Plaintiff plan to appeal. If you or a loved one have bladder cancer and have taken Actos to treat Type 2 diabetes for a long period of time, please contact an experienced lawyer, in Central Illinois Ryan Bradley and the Law Firm of Phebus & Koester strive to bring justice to all people–including victims of Actos.